PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cells
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.IQGAP3 promotes triple-negative breast cancer (TNBC) cell migration and invasion by regulating cell contractility. Targeting the PAK6-IQGAP3-RhoA pathway may offer new therapeutic strategies for TNBC patients.
Area Of Science
- Oncology
- Cell Biology
- Molecular Biology
Background
- Breast cancer is a leading cause of cancer death in women globally.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted therapies.
- IQGAP3 is a protein found to be upregulated in TNBC tumors.
Purpose Of The Study
- To investigate the role of IQGAP3 in TNBC cell behavior.
- To elucidate the molecular mechanisms underlying IQGAP3's function in breast cancer.
Main Methods
- Depletion of IQGAP3 expression in TNBC cell lines.
- Analysis of cell morphology, migration, and invadopodia formation.
- Assessment of RhoA activity and actomyosin contractility.
- Investigation of the interaction between IQGAP3 and PAK6.
Main Results
- IQGAP3 depletion caused cell elongation, reduced migration, and inhibited invadopodia formation.
- IQGAP3 regulates cell morphology and invasion via the RhoA pathway.
- IQGAP3 interacts with PAK6, and PAK6 plays a crucial role in the observed phenotype.
Conclusions
- A novel PAK6-IQGAP3-RhoA pathway is identified, driving breast cancer cell contractility, migration, and invasion.
- This pathway is critical for metastasis and re-seeding of tumors.
- Pharmacological targeting of PAK6 presents a potential therapeutic strategy for TNBC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
